Business Description
![Biostax Corp Biostax Corp logo](https://static.gurufocus.com/logos/0C00006F4D.png?14)
Biostax Corp
NAICS : 325412
SIC : 2834
ISIN : US45252A1079
Description
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -1060.6 | |||||
Debt-to-Equity | -0.22 | |||||
Debt-to-EBITDA | -0.61 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 83.4 | |||||
3-Year FCF Growth Rate | 77.1 | |||||
3-Year Book Growth Rate | 87 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 71.12 | |||||
9-Day RSI | 72.9 | |||||
14-Day RSI | 72.17 | |||||
6-1 Month Momentum % | -1.97 | |||||
12-1 Month Momentum % | -80.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -459.9 | |||||
Shareholder Yield % | -3.33 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -722.55 | |||||
ROIC % | -80.53 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Free-Cash-Flow | 47.5 | |||||
Price-to-Operating-Cash-Flow | 47.5 | |||||
EV-to-EBIT | -5.76 | |||||
EV-to-EBITDA | -5.84 | |||||
EV-to-FCF | 82.49 | |||||
Earnings Yield (Greenblatt) % | -17.36 | |||||
FCF Yield % | 1.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BTAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biostax Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.029 | ||
Beta | 0.23 | ||
Volatility % | 88.47 | ||
14-Day RSI | 72.17 | ||
14-Day ATR ($) | 0.014176 | ||
20-Day SMA ($) | 0.057675 | ||
12-1 Month Momentum % | -80.07 | ||
52-Week Range ($) | 0.032 - 0.33 | ||
Shares Outstanding (Mil) | 83.74 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biostax Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biostax Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Biostax Corp Frequently Asked Questions
What is Biostax Corp(BTAX)'s stock price today?
The current price of BTAX is $0.10. The 52 week high of BTAX is $0.33 and 52 week low is $0.03.
When is next earnings date of Biostax Corp(BTAX)?
The next earnings date of Biostax Corp(BTAX) is 2024-11-14 Est..
Does Biostax Corp(BTAX) pay dividends? If so, how much?
Biostax Corp(BTAX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |